HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marie, J. Articles by Bonnafous, J. C. Search for Related Content PubMed PubMed Citation Articles by Marie, J. Articles by Bonnafous, J. C. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 33, 20815-20818, 08, 1994

Tyr292 in the seventh transmembrane domain of the AT1A angiotensin II receptor is essential for its coupling to phospholipase C

J Marie, B Maigret, MP Joseph, R Larguier, S Nouet, C Lombard and JC Bonnafous
INSERM, Unite 401, CCIPE, Montpellier, France.

An essential role of the conserved Asp74 in the coupling of the type 1 angiotensin II (AII) receptor (AT1) to phospholipase C has already been reported (Bihoreau, C., Monnot, C., Davies, E., Teutsch, B., Bernstein, K. B., Corvol, P., and Clauser, E. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5133-5137). Moreover, preliminary modeling studies have shown that a spatial proximity exists between Asp74, located in transmembrane domain II, and Tyr292, located in transmembrane domain VII and conserved in many, but not all, G protein-coupled receptors. We mutated Tyr292 into Phe and evaluated the pharmacological and activation characteristics of the mutated receptor (Y292F) stably expressed in Chinese hamster ovary cells. This receptor possessed unchanged binding properties for agonist or antagonist peptide ligands compared to the wild-type receptor, while its coupling to phospholipase C was severely impaired. Interestingly, competition binding experiments, using 125I- [Sar1]AII as a tracer ligand, showed that the Y292F receptor displayed an increased Ki value for DuP 753, an AT1-specific nonpeptide antagonist and a greatly decreased Ki value for the AT2-specific ligand CGP 42112A. These pharmacological changes are similar to those observed for the previously reported mutation of Asp74 into Asn. This apparently symmetrical role of Asp74 and Tyr292 is consistent with the hypothesis that an interaction between these two amino acids could be a key event in the molecular processes linking AII recognition and AT1 receptor activation.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure Physiol Rev, April 1, 2007; 87(2): 565 - 592. [Abstract] [Full Text] [PDF]

				D. K. Yee, A. Suzuki, L. Luo, and S. J. Fluharty Identification of Structural Determinants for G Protein-Independent Activation of Mitogen-Activated Protein Kinases in the Seventh Transmembrane Domain of the Angiotensin II Type 1 Receptor Mol. Endocrinol., August 1, 2006; 20(8): 1924 - 1934. [Abstract] [Full Text] [PDF]

				S.-i. Miura, M. Fujino, H. Hanzawa, Y. Kiya, S. Imaizumi, Y. Matsuo, S. Tomita, Y. Uehara, S. S. Karnik, H. Yanagisawa, et al. Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor J. Biol. Chem., July 14, 2006; 281(28): 19288 - 19295. [Abstract] [Full Text] [PDF]

				Y.-H. Feng, L. Zhou, R. Qiu, and R. Zeng Single Mutations at Asn295 and Leu305 in the Cytoplasmic Half of Transmembrane {alpha}-Helix Domain 7 of the AT1 Receptor Induce Promiscuous Agonist Specificity for Angiotensin II Fragments: A Pseudo-Constitutive Activity Mol. Pharmacol., August 1, 2005; 68(2): 347 - 355. [Abstract] [Full Text] [PDF]

				M. Clement, S. S. Martin, M.-E. Beaulieu, C. Chamberland, P. Lavigne, R. Leduc, G. Guillemette, and E. Escher Determining the Environment of the Ligand Binding Pocket of the Human Angiotensin II Type I (hAT1) Receptor Using the Methionine Proximity Assay J. Biol. Chem., July 22, 2005; 280(29): 27121 - 27129. [Abstract] [Full Text] [PDF]

				R. P. Millar, Z.-L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley Gonadotropin-Releasing Hormone Receptors Endocr. Rev., April 1, 2004; 25(2): 235 - 275. [Abstract] [Full Text] [PDF]

				A. A. Boucard, M. Roy, M.-E. Beaulieu, P. Lavigne, E. Escher, G. Guillemette, and R. Leduc Constitutive Activation of the Angiotensin II Type 1 Receptor Alters the Spatial Proximity of Transmembrane 7 to the Ligand-binding Pocket J. Biol. Chem., September 19, 2003; 278(38): 36628 - 36636. [Abstract] [Full Text] [PDF]

				S.-i. Miura, J. Zhang, J. Boros, and S. S. Karnik TM2-TM7 Interaction in Coupling Movement of Transmembrane Helices to Activation of the Angiotensin II Type-1 Receptor J. Biol. Chem., January 31, 2003; 278(6): 3720 - 3725. [Abstract] [Full Text] [PDF]

				S.-i. Miura and S. S. Karnik Constitutive Activation of Angiotensin II Type 1 Receptor Alters the Orientation of Transmembrane Helix-2 J. Biol. Chem., June 28, 2002; 277(27): 24299 - 24305. [Abstract] [Full Text] [PDF]

				K.-L. Hoe and J. M. Saavedra Site-Directed Mutagenesis of the Gerbil and Human Angiotensin II AT1 Receptors Identifies Amino Acid Residues Attributable to the Binding Affinity for the Nonpeptidic Antagonist Losartan Mol. Pharmacol., June 1, 2002; 61(6): 1404 - 1415. [Abstract] [Full Text] [PDF]

				M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF]

				S. Bastian, D. Pruneau, B. Loillier, C. Robert, J.-C. Bonnafous, and J.-L. Paquet Identification of a Key Region of Kinin B1 Receptor for High Affinity Binding of Peptide Antagonists J. Biol. Chem., February 25, 2000; 275(9): 6107 - 6113. [Abstract] [Full Text] [PDF]

				K. Befort, C. Zilliox, D. Filliol, S. Yue, and B. L. Kieffer Constitutive Activation of the delta  Opioid Receptor by Mutations in Transmembrane Domains III and VII J. Biol. Chem., June 25, 1999; 274(26): 18574 - 18581. [Abstract] [Full Text] [PDF]

				S.-i. Miura, Y.-H. Feng, A. Husain, and S. S. Karnik Role of Aromaticity of Agonist Switches of Angiotensin II in the Activation of the AT1 Receptor J. Biol. Chem., March 12, 1999; 274(11): 7103 - 7110. [Abstract] [Full Text] [PDF]

				J. Marie, C. Koch, D. Pruneau, J.-L. Paquet, T. Groblewski, R. Larguier, C. Lombard, B. Deslauriers, B. Maigret, and J.-C. Bonnafous Constitutive Activation of the Human Bradykinin B2 Receptor Induced by Mutations in Transmembrane Helices III and VI Mol. Pharmacol., January 1, 1999; 55(1): 92 - 101. [Abstract] [Full Text]

				L. Hunyady, H. Ji, G. Jagadeesh, M. Zhang, Z. Gáborik, B. Mihalik, and K. J. Catt Dependence of AT1 Angiotensin Receptor Function on Adjacent Asparagine Residues in the Seventh Transmembrane Helix Mol. Pharmacol., August 1, 1998; 54(2): 427 - 434. [Abstract] [Full Text]

				A. Jagerschmidt, N. Guillaume, B. P. Roques, and F. Noble Binding Sites and Transduction Process of the CholecystokininB Receptor: Involvement of Highly Conserved Aromatic Residues of the Transmembrane Domains Evidenced by Site-Directed Mutagenesis Mol. Pharmacol., May 1, 1998; 53(5): 878 - 885. [Abstract] [Full Text]

				B. Fisslthaler, V. B Schini-Kerth, I. Fleming, and R. Busse Thrombin receptor expression is increased by angiotensin II in cultured and native vascular smooth muscle cells Cardiovasc Res, April 1, 1998; 38(1): 263 - 271. [Abstract] [Full Text] [PDF]

				S. Conchon, M.-B. Barrault, S. Miserey, P. Corvol, and E. Clauser The C-terminal Third Intracellular Loop of the Rat AT1A Angiotensin Receptor Plays a Key Role in G Protein Coupling Specificity and Transduction of the Mitogenic Signal J. Biol. Chem., October 10, 1997; 272(41): 25566 - 25572. [Abstract] [Full Text] [PDF]

				T. Sano, K. Ohyama, Y. Yamano, Y. Nakagomi, S. Nakazawa, M. Kikyo, H. Shirai, J. S. Blank, J. H. Exton, and T. Inagami A Domain for G Protein Coupling in Carboxyl-terminal Tail of Rat Angiotensin II Receptor Type 1A J. Biol. Chem., September 19, 1997; 272(38): 23631 - 23636. [Abstract] [Full Text] [PDF]

				B. C. Berk and M. A. Corson Angiotensin II Signal Transduction in Vascular Smooth Muscle : Role of Tyrosine Kinases Circ. Res., May 19, 1997; 80(5): 607 - 616. [Abstract] [Full Text]

				T. Groblewski, B. Maigret, R. Larguier, C. Lombard, J.-C. Bonnafous, and J. Marie Mutation of Asn111 in the Third Transmembrane Domain of the AT1A Angiotensin II Receptor Induces Its Constitutive Activation J. Biol. Chem., January 17, 1997; 272(3): 1822 - 1826. [Abstract] [Full Text] [PDF]

				C. Monnot, C. Bihoreau, S. Conchon, K. M. Curnow, P. Corvol, and E. Clauser Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling J. Biol. Chem., January 19, 1996; 271(3): 1507 - 1513. [Abstract] [Full Text] [PDF]

				K. Noda, Y. Saad, and S. S. Karnik Interaction of Phe^8 of Angiotensin II with Lys[IMAGE] and His[IMAGE] of AT(1) Receptor in Agonist Activation J. Biol. Chem., December 1, 1995; 270(48): 28511 - 28514. [Abstract] [Full Text] [PDF]

				Lás. Hunyady, Már. Bor, A. J. Baukal, T.ás Balla, and K. J. Catt A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor J. Biol. Chem., July 14, 1995; 270(28): 16602 - 16609. [Abstract] [Full Text] [PDF]

				C. Wang, S. Jayadev, and J. A. Escobedo Identification of a Domain in the Angiotensin II Type 1 Receptor Determining G[IMAGE] Coupling by the Use of Receptor Chimeras J. Biol. Chem., July 14, 1995; 270(28): 16677 - 16682. [Abstract] [Full Text] [PDF]

				Y.-H. Feng, K. Noda, Y. Saad, X.-p. Liu, A. Husain, and S. S. Karnik The Docking of Arg[IMAGE] of Angiotensin II with Asp[IMAGE] of AT[IMAGE] Receptor Is Essential for Full Agonism J. Biol. Chem., May 26, 1995; 270(21): 12846 - 12850. [Abstract] [Full Text] [PDF]

				Lás. Hunyady, Már. Bor, T.ás Balla, and K. J. Catt Critical Role of a Conserved Intramembrane Tyrosine Residue in Angiotensin II Receptor Activation J. Biol. Chem., April 28, 1995; 270(17): 9702 - 9705. [Abstract] [Full Text] [PDF]

				H. Shirai, K. Takahashi, T. Katada, and T. Inagami Mapping of G Protein Coupling Sites of the Angiotensin II Type 1 Receptor Hypertension, April 1, 1995; 25(4): 726 - 730. [Abstract] [Full Text]

				K. Noda, Y. Saad, A. Kinoshita, T. P. Boyle, R. M. Graham, A. Husain, and S. S. Karnik Tetrazole and Carboxylate Groups of Angiotensin Receptor Antagonists Bind to the Same Subsite by Different Mechanisms J. Biol. Chem., February 3, 1995; 270(5): 2284 - 2289. [Abstract] [Full Text] [PDF]

				T. N. Doan, M. S. Ali, and K. E. Bernstein Tyrosine Kinase Activation by the Angiotensin II Receptor in the Absence of Calcium Signaling J. Biol. Chem., June 8, 2001; 276(24): 20954 - 20958. [Abstract] [Full Text] [PDF]

				J. Marie, E. Richard, D. Pruneau, J.-L. Paquet, C. Siatka, R. Larguier, C. Ponce, P. Vassault, T. Groblewski, B. Maigret, et al. Control of Conformational Equilibria in the Human B2 Bradykinin Receptor. MODELING OF NONPEPTIDIC LIGAND ACTION AND COMPARISON TO THE RHODOPSIN STRUCTURE J. Biol. Chem., October 26, 2001; 276(44): 41100 - 41111. [Abstract] [Full Text] [PDF]